Jeil Pharma Holdings Inc (002620.KS)

KRW 7990.0

(-3.5%)

Long Term Debt Summary of Jeil Pharma Holdings Inc

  • Jeil Pharma Holdings Inc's latest annual long term debt in 2023 was 10.5 Billion KRW , down -39.92% from previous year.
  • Jeil Pharma Holdings Inc's latest quarterly long term debt in 2024 Q2 was 11.9 Billion KRW , up 21.43% from previous quarter.
  • Jeil Pharma Holdings Inc reported annual long term debt of 17.47 Billion KRW in 2022, down -13.08% from previous year.
  • Jeil Pharma Holdings Inc reported annual long term debt of 20.1 Billion KRW in 2021, up 59.78% from previous year.
  • Jeil Pharma Holdings Inc reported quarterly long term debt of 9.8 Billion KRW for 2024 Q1, down -6.67% from previous quarter.
  • Jeil Pharma Holdings Inc reported quarterly long term debt of 13.25 Billion KRW for 2023 Q2, down -3.39% from previous quarter.

Annual Long Term Debt Chart of Jeil Pharma Holdings Inc (2023 - 2007)

Historical Annual Long Term Debt of Jeil Pharma Holdings Inc (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 10.5 Billion KRW -39.92%
2022 17.47 Billion KRW -13.08%
2021 20.1 Billion KRW 59.78%
2020 12.58 Billion KRW -10.76%
2019 14.1 Billion KRW -29.16%
2018 19.9 Billion KRW 0.0%
2017 - KRW -100.0%
2016 27.5 Billion KRW 450.0%
2015 5 Billion KRW -28.57%
2014 7 Billion KRW -12.5%
2013 8 Billion KRW 0.0%
2012 8 Billion KRW 0.0%
2011 - KRW 0.0%
2010 - KRW 0.0%
2009 - KRW 0.0%
2008 - KRW -100.0%
2007 60 Million KRW 0.0%

Peer Long Term Debt Comparison of Jeil Pharma Holdings Inc

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW 23.021%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 94.804%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 64.855%
HANDOK Inc. 123.78 Billion KRW 91.517%
Kukje Pharma Co., Ltd. 475.74 Million KRW -2107.075%
Yuhan Corporation 60.23 Billion KRW 82.568%
Dong-A ST Co., Ltd. 161.99 Billion KRW 93.518%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -10212.54%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 87.2%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -1678.729%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -73.554%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 43.312%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW 16.562%
Hana Pharm Co., Ltd. 1.59 Billion KRW -556.724%
Yuyu Pharma, Inc. 13.64 Billion KRW 23.021%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -8673.513%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 91.322%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 67.188%
JW Holdings Corporation 20.65 Billion KRW 49.171%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW 29.175%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 65.0%
JW Pharmaceutical Corporation 30 Billion KRW 65.0%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -4695.375%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -1708.33%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 78.817%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW -135.849%
Yuyu Pharma, Inc. 13.64 Billion KRW 23.021%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 44.817%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 88.76%
JW Pharmaceutical Corporation 30 Billion KRW 65.0%
Yuhan Corporation 60.23 Billion KRW 82.568%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 73.996%
Suheung Co., Ltd. 74 Billion KRW 85.812%
JW Pharmaceutical Corporation 30 Billion KRW 65.0%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW -152.002%
Korea United Pharm Inc. 10.96 Billion KRW 4.219%
CKD Bio Corp. 69.43 Billion KRW 84.877%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 69.631%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW 34.895%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -3319.569%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -4695.375%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 85.439%
Boryung Corporation 151.7 Billion KRW 93.079%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 86.628%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -73.554%
JW Lifescience Corporation 168 Million KRW -6150.0%